SEC Form 4 · accession 0001104659-19-009040
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonardus H.T. Van der Ploeg
Officer — Chief Scientific Officer
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $29.78 | Feb 13, 2019 | A | 70,000 | A | — | Feb 12, 2029 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1This option was granted on February 13, 2019 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 13, 2019.